The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual…

Overview of attention for article published in BMC Medicine, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

policy: 2 policy sources
twitter: 26 X users

facebook: 1 Facebook page
guideline: 1 clinical guideline source

Readers on

mendeley: 149 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

Cited by Centers for Disease Control and Prevention (CDC) on 01 Feb 2024

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

WHO guidelines for malaria, 25 November 2022

Cited by World Health Organization (WHO) on 01 Jan 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.